Advertisement
The leading life science news channel in the Nordic region.
Agreement - February 13, 2024
The joint venture will commercialize and distribute selected Sobi medicines in South Korea. The joint venture, due for incorporation in the first half of this year, is expected to enhance the Sobi and Handok collaboration, they state. Strengthening their position in the rare disease business, Handok and Sobi aim to develop, commercialize and distribute Sobi’s […]
Global report - February 12, 2024
During the Christmas holidays, the automatic filling of the cryotanks with liquid nitrogen was interrupted for an unknown reason in the Neo building on the institute’s Flemingsberg campus. As a result of the failure, the temperature in 16 of 19 cryogenic tanks rose and large amounts of biological research material dating back decades have been […]
Prio - February 12, 2024
Nordic Life Science asked Lene Gerlach, Partner, Eir Ventures, about her predictions for 2024, including market trends, financing opportunities for SMEs and business strategy advice. What do you predict will be the dominant market trend within life sciences this year? “In the broader perspective, the market trend is steadily shifting towards prioritizing disease prevention over […]
Financing - February 12, 2024
Nordic Life Science asked Casper Breum, Managing Partner, Sound Bioventures, about his predictions for 2024, including market trends, financing opportunities for SMEs and business strategy advice. What do you predict will be the dominant market trend within life sciences this year? “A continued and increased focus on cost and value for money in healthcare. The […]
Clinical Trials - February 12, 2024
Orexo and Swedish Orphan Biovitrum (Sobi) have agreed to advance their exploratory feasibility study with AmorphOX initiated last year. The feasibility study primarily assessed whether the biomolecule could be formulated in AmorphOX with retained activity. The continued collaboration will evaluate if the AmorphOX technology could add unique properties to one of Sobi’s biomolecules. Orexo has […]
Financing - February 12, 2024
Nordic Life Science asked Ingrid Teigland Akay, Managing Partner, Hadean Ventures, about her predictions for 2024, including market trends, financing opportunities for SMEs and business strategy advice. What do you predict will be the dominant market trend within life sciences this year? “The life science industry is in many ways in a good position. There […]
Acquisition - February 12, 2024
RaySearch have announces the acquisition of DrugLog from Pharmacolog for the purchase price of SEK 7 million. DrugLog is a solution for verifying the identity and concentration of compounded injectable medications, used for cancer treatment with cytostatic drugs (chemotherapy). Through this agreement, RaySearch acquires full ownership of all rights to the product for its application […]
Financing - February 12, 2024
Nordic Life Science asked Dan Akschuti, Equity Partner/Biotech Analyst, Pareto Securities, about his predictions for 2024, including market trends, financing opportunities for SMEs and business strategy advice. What do you predict will be the dominant market trend within life sciences this year? “Expected increased focus on late-stage (post phase 2) and commercial-stage companies while seeing […]
Financing - February 12, 2024
Nordic Life Science asked Pekka Simula, Partner, Innovestor Life Science, about his predictions for 2024, including market trends, financing opportunities for SMEs and business strategy advice. What do you predict will be the dominant market trend within life sciences this year? “In the Nordics, syndication. Even while globally there’s talk about syndication being passé because […]
Collaboration - February 12, 2024
This year’s International Women and Girls in Science Day, implemented by UNESCO and UN-Women, focused on Closing the gender gap in science: Accelerating action. Despite the progress made in recent decades, still today only one in three researchers globally is a woman, describes UNESCO. This persistent gender disparity is the result of the numerous barriers […]
This site uses cookies